Literature DB >> 30042232

The lateral meningocele syndrome mutation causes marked osteopenia in mice.

Ernesto Canalis1,2,3, Jungeun Yu4,3, Lauren Schilling4,3, Siu-Pok Yee5,6, Stefano Zanotti4,2,3.   

Abstract

Lateral meningocele syndrome (LMS) is a rare genetic disorder characterized by neurological complications and osteoporosis. LMS is associated with mutations in exon 33 of NOTCH3 leading to a truncated protein lacking sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function. To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9 to introduce a tandem termination codon at bases 6691-6696 (ACCAAG→TAATGA) and verified this mutation (Notch3tm1.1Ecan ) by DNA sequencing of F1 mice. One-month-old male and female heterozygous Notch3tm1.1Ecan mice had cancellous and cortical bone osteopenia but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60% decrease in cancellous bone volume associated with a reduction in trabecular number and decreased connectivity. During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous bone osteopenia at 4 months. Cancellous bone histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate. Notch3tm1.1Ecan calvarial osteoblasts had increased proliferation and increased bone γ-carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3tm1.1Ecan mice. Cultures of bone marrow-derived macrophages from Notch3tm1.1Ecan mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts from Notch3tm1.1Ecan mice. In conclusion, the Notch3tm1.1Ecan mutation causes osteopenia despite an increase in osteoblast proliferation and function and is associated with enhanced Tnfsf11 expression in osteoblasts and osteocytes.
© 2018 Canalis et al.

Entities:  

Keywords:  Lehman syndrome; Notch receptor; bone; bone loss; lateral meningocele syndrome; osteoblast; osteoclast; osteocyte; osteopenia; skeletal abnormalities

Mesh:

Substances:

Year:  2018        PMID: 30042232      PMCID: PMC6130932          DOI: 10.1074/jbc.RA118.004242

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

1.  A new collagenase blend increases the number of islets isolated from mouse pancreas.

Authors:  Pinar Yesil; Marcus Michel; Karolina Chwalek; Stephanie Pedack; Cordula Jany; Barbara Ludwig; Stefan R Bornstein; Eckhard Lammert
Journal:  Islets       Date:  2009 Nov-Dec       Impact factor: 2.694

2.  Dimorphic effects of Notch signaling in bone homeostasis.

Authors:  Feyza Engin; Zhenqiang Yao; Tao Yang; Guang Zhou; Terry Bertin; Ming Ming Jiang; Yuqing Chen; Lisa Wang; Hui Zheng; Richard E Sutton; Brendan F Boyce; Brendan Lee
Journal:  Nat Med       Date:  2008-02-24       Impact factor: 53.440

3.  Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.

Authors:  Stefano Zanotti; Jungeun Yu; Archana Sanjay; Lauren Schilling; Chris Schoenherr; Aris N Economides; Ernesto Canalis
Journal:  J Biol Chem       Date:  2017-06-07       Impact factor: 5.157

4.  Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis.

Authors:  Zhiyuan Zhang; Hao Wang; Sadakatsu Ikeda; Frederic Fahey; Diane Bielenberg; Patrick Smits; Peter V Hauschka
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

5.  Validation of peripheral dual-energy X-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats.

Authors:  T R Nagy; C W Prince; J Li
Journal:  J Bone Miner Res       Date:  2001-09       Impact factor: 6.741

6.  Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.

Authors:  J Ignacio Aguirre; Lilian I Plotkin; Scott A Stewart; Robert S Weinstein; A Michael Parfitt; Stavros C Manolagas; Teresita Bellido
Journal:  J Bone Miner Res       Date:  2006-04-05       Impact factor: 6.741

7.  Hajdu-Cheney syndrome with severe dural ectasia.

Authors:  Kristiina Avela; Leena Valanne; Ilkka Helenius; Outi Mäkitie
Journal:  Am J Med Genet A       Date:  2011-02-18       Impact factor: 2.802

8.  Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

Authors:  Takashi Nakamura; Yuuki Imai; Takahiro Matsumoto; Shingo Sato; Kazusane Takeuchi; Katsuhide Igarashi; Yoshifumi Harada; Yoshiaki Azuma; Andree Krust; Yoko Yamamoto; Hiroshi Nishina; Shu Takeda; Hiroshi Takayanagi; Daniel Metzger; Jun Kanno; Kunio Takaoka; T John Martin; Pierre Chambon; Shigeaki Kato
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

9.  The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis.

Authors:  Hidefumi Fukushima; Akihiro Nakao; Fujio Okamoto; Masashi Shin; Hiroshi Kajiya; Seiji Sakano; Anna Bigas; Eijiro Jimi; Koji Okabe
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

10.  Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design tool.

Authors:  Jeffry D Sander; Peter Zaback; J Keith Joung; Daniel F Voytas; Drena Dobbs
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

View more
  12 in total

Review 1.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

2.  Nuclear factor of activated T cells 1 and 2 are required for vertebral homeostasis.

Authors:  Ernesto Canalis; Lauren Schilling; Tabitha Eller; Jungeun Yu
Journal:  J Cell Physiol       Date:  2020-04-24       Impact factor: 6.384

3.  An antibody to Notch3 reverses the skeletal phenotype of lateral meningocele syndrome in male mice.

Authors:  Jungeun Yu; Christian W Siebel; Lauren Schilling; Ernesto Canalis
Journal:  J Cell Physiol       Date:  2019-06-12       Impact factor: 6.384

4.  Antisense oligonucleotides targeting Notch2 ameliorate the osteopenic phenotype in a mouse model of Hajdu-Cheney syndrome.

Authors:  Ernesto Canalis; Tamar R Grossman; Michele Carrer; Lauren Schilling; Jungeun Yu
Journal:  J Biol Chem       Date:  2020-01-28       Impact factor: 5.157

5.  The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  J Biol Chem       Date:  2019-08-01       Impact factor: 5.157

Review 6.  The Progress of CRISPR/Cas9-Mediated Gene Editing in Generating Mouse/Zebrafish Models of Human Skeletal Diseases.

Authors:  Nan Wu; Bowen Liu; Huakang Du; Sen Zhao; Yaqi Li; Xi Cheng; Shengru Wang; Jiachen Lin; Junde Zhou; Guixing Qiu; Zhihong Wu; Jianguo Zhang
Journal:  Comput Struct Biotechnol J       Date:  2019-06-13       Impact factor: 7.271

Review 7.  Genomic Medicine: Lessons Learned From Monogenic and Complex Bone Disorders.

Authors:  Katerina Trajanoska; Fernando Rivadeneira
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-09       Impact factor: 5.555

Review 8.  The Skeleton of Lateral Meningocele Syndrome.

Authors:  Ernesto Canalis
Journal:  Front Genet       Date:  2021-01-14       Impact factor: 4.599

9.  Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling.

Authors:  Ernesto Canalis; Stefano Zanotti; Lauren Schilling; Tabitha Eller; Jungeun Yu
Journal:  J Biol Chem       Date:  2021-03-24       Impact factor: 5.157

Review 10.  Genome editing methods in animal models.

Authors:  Hyunji Lee; Da Eun Yoon; Kyoungmi Kim
Journal:  Anim Cells Syst (Seoul)       Date:  2020-02-17       Impact factor: 1.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.